top of page
Multidisciplinary Approaches in Pancreatic Cancer Care with Dr. Adam Yopp, Dr. Arsen Osipov, Dr. Andrew Hendifar on the BackTable Tumor Board Podcast
00:00 / 01:04
loading.gif

Save your progress. Continue watching on the BackTable app.

BackTable Tumor Board

Episode # 3  •  17 Jan 2025

Multidisciplinary Approaches in Pancreatic Cancer Care

At Cedars-Sinai, the time from a pancreatic cancer diagnosis to the first dose of chemotherapy fell from about a month to 14 days, and trial enrollment nearly tripled, once every specialist started seeing the patient in the same room on the same day. On this episode of the BackTable GI Oncology Creator Weekend™, medical oncologist Dr. Andrew Hendifar of Cedars-Sinai is joined by surgical oncologist Dr. Adam Yopp, chief of surgical oncology at UT Southwestern, and GI medical oncologist Dr. Arsen Osipov of Cedars-Sinai to compare how their same-day multidisciplinary clinics run and what every clinic needs, from an experienced pancreatic surgeon and a radiation oncologist to genetic counseling, an early dietitian visit, and supportive care. They also explain how virtual tumor boards, same-week biopsy slots, and outreach networks bring community oncologists in Texas and California into the plan, and weigh whether pancreatic cancer care should be regionalized, as it is in parts of Canada.

Timestamps

00:00 - Introduction
01:48 - What Multidisciplinary Care Means in Pancreatic Cancer
04:37 - Same-Day Clinics, Time to Treatment, and Trial Enrollment
07:38 - Virtual Tumor Boards and Community Outreach
11:00 - Regionalization of Pancreatic Cancer Care
13:04 - Building Blocks of a Multidisciplinary Clinic
15:55 - Robotic Pancreaticoduodenectomy: Volume and Learning Curve
21:20 - Recovery After Robotic Surgery and Conversion to Open
23:48 - KRAS Inhibitors and Tumor Treating Fields in Localized Disease
26:20 - Will KRAS Inhibitors Send More Patients to Surgery?
30:39 - SBRT and Radiation in the Multidisciplinary Plan
35:41 - Solitary Liver or Lung Recurrence
39:27 - Closing Remarks

You may also like

See more of the content that's relevant to your practice.

More about this episode

Dr. Adam Yopp says about 95% of pancreaticoduodenectomies at UT Southwestern are now done robotically, including cases with vein and arterial resections, and describes what roughly 1,000 cases have taught his team about the learning curve, four-hour operations, shorter hospital stays, and having two attending surgeons share every case. He and Dr. Arsen Osipov weigh KRAS inhibitors moving into localized disease after the RASolute 302 results in metastatic disease, tumor treating fields for locally advanced disease, and what a negative Alliance neoadjuvant trial could mean for practice. The surgeon and medical oncologists also compare their selective use of stereotactic body radiation therapy (SBRT), why chemoradiation has largely faded, and when a solitary liver or lung recurrence years after surgery deserves a second look at local treatment.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page